semaglutide and bipolar A Case of Semaglutide-Induced Euphoria in a Patient With Disorder semaglutide bipolar semaglutide depression anxiety

Presented for research literature review only Sumithran P et al

Semaglutide works by triggering GLP-1 receptors in the brain, which reduces food intake and increases feelings of fullness

The plateau feels like failure

As of mid-2026, Retatrutide has completed its first successful Phase 3 trial (TRIUMPH-1, reported May 2026), with seven further Phase 3 trials expected to report throughout 2026 covering different patient groups and outcomes

Have a one-page table of daily versus weekly stop timelines, last dose timestamp, and glucose-monitoring instructions for easy handoff reference

For optimal results, a combination of treatments, a balanced diet, and regular exercise may be recommended.